Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Measurement of Bioavailability: Pharmacodynamic Methods

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Feature Down-Selection to Improve Supervised Classification by Machine Learning on Mass Spectrometry Imaging Data.

Molecules (Basel, Switzerland)·2026

Same author

Quantitative determination of longitudinal CNS cholesterol loss during myelin damage and repair.

bioRxiv : the preprint server for biology·2026

Same author

Lipidomics in Children: Noninvasive Sebum Sampling in Children and Adults Allows for Assessment of Lipidomic Differences According to Age, Sex, and Biological Relatedness.

Analytical chemistry·2026

Same author

Almost Nobody Is Using ChatGPT to Write Academic Science Papers (Yet).

Big data and cognitive computing·2025

Same author

Exploring Sample Storage Conditions for the Mass Spectrometric Analysis of Extracted Lipids from Latent Fingerprints.

Biomolecules·2025

Same author

Groomed Fingerprint Sebum Sampling: Reproducibility and Variability According to Anatomical Collection Region and Biological Sex.

Molecules (Basel, Switzerland)·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

The STEP method (statistical test of equivalent pathways): application to pharmaceuticals.

Mary L Bandu¹, Heather Desaire

¹Department of Chemistry, The University of Kansas, Lawrence, Kansas66045, USA.

|January 28, 2006

Summary

The Statistical Test of Equivalent Pathways (STEP) method aids in analyzing pharmaceutical antibiotic fragmentation. While generally effective, it may misclassify fragile ions like erythromycin, indicating a potential limitation and a new diagnostic possibility.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Area of Science:

Analytical Chemistry
Mass Spectrometry
Pharmaceutical Analysis

Background:

The Statistical Test of Equivalent Pathways (STEP) is a recent method for analyzing MS/MS fragmentation patterns.
Understanding primary and secondary fragmentation is crucial for structural elucidation of peptides and carbohydrates.
Application of STEP to pharmaceutical compounds requires validation.

Purpose of the Study:

To apply the STEP method to common pharmaceutical antibiotics for fragmentation analysis.
To construct genealogy diagrams for structural characterization of product ions.
To identify limitations and potential applications of STEP analysis in pharmaceuticals.

Main Methods:

MS/MS analysis of four pharmaceutical antibiotic compounds.
Application of the STEP method to classify product ions as primary or secondary.
Construction of genealogy diagrams based on STEP classifications.

Main Results:

The STEP method successfully identified primary and secondary ions in three out of four tested pharmaceuticals.
Discrepancies were observed for erythromycin, where STEP values did not align with established fragmentation assignments.
Fragile ions, like erythromycin, can yield abnormally low STEP ratios, potentially leading to inaccurate classifications.

Conclusions:

The STEP method has limitations when applied to fragile pharmaceutical ions, potentially causing misclassification of fragmentation pathways.
STEP analysis may serve as an indicator for the presence of fragile ions in a sample.
Further investigation is needed to refine STEP methodology for complex pharmaceutical fragmentation analysis.